The global genomic biomarker market is anticipated to grow at a considerable CAGR of 10% during the forecast. The market growth is attributed to the increasing prevalence of chronic diseases such as cancer and cardiovascular diseases. Cancer is one of the major causes of mortality across the globe.
Browse the full report description Genomic Biomarker Market by Disease Indication (Oncology, Cardiology, Neurology, Others), By End-Users (Hospitals, Diagnostic and Research Laboratories) - Global Industry Share, Growth, Competitive Analysis and Forecast Period 2020-2027 at https://www.omrglobal.com/industry-reports/genomic-biomarkers-market
According to the American Cancer Society In 2020, there were an estimated 1.8 million new cancer cases diagnosed and 606,520 cancer deaths in the US. Due to the increasing burden of cancer, the players are expected to have higher priorities concerning the expansion of products in the field of oncology.
Market coverage
o By Disease Indication
o By End-User
o North America
o Europe
o Asia-Pacific
o Rest of the world
Key Questions Addressed by the Report
o Deviation from the pre-covid-19 forecast
o Most affected region and segment
Global Genomic Biomarker market report segment
By Disease Indication
By End-User
Global Genomic Biomarker Market Report Segment by Region
North America
Europe
Asia-Pacific
Rest of the World
To learn more about this report request a free sample copy
@ https://www.omrglobal.com/request-sample/genomic-biomarkers-market